Author:
Dahm Georges,Roschel Karin,Marson Claude,Bourmaud Adèle,Macedo Jennifer,Lupo Mauro,Fauchet Lionel,Allar Claudia,Schaaf Raoul,Schneider Serge
Abstract
Abstract
Background
Drug consumption rooms offer heroin and cocaine consumers a secure and hygienic environment including medical and social guidance. Despite the support and mentoring, only sparse information is available about how drug quality, drug prices and user expectations match at these locations. The present study reports analysis of these three parameters in two drug consumption rooms in Luxembourg.
Methods
Drug users were invited to participate in the project by handing in a few milligrams of the product they planned to consume for chemical analysis and filling out a short questionnaire about the price and their expectations. After consumption, they were asked to report the experienced effects. Drug quality was accessed using LC-Q-ToF and HPLC–UV, and a statistical analysis was carried out of the questionnaires that were correctly filled out.
Results
A total of 513 drug samples have been analyzed. Most consumers were looking for the relaxing/calming effects of heroin and the stimulating effects of cocaine, but they generally overestimated heroin potency and underestimated cocaine potency. No strong correlation based on Spearman’s ρ between drug user estimations, drug prices and drug quality was found.
Conclusion
To the best of our knowledge, this study is the first to combine drug analysis with heroin and cocaine user feedback about expectation, drug prices and drug effects. The analytical results were of great interest for users and the staff working at the drug consumption rooms. They may be a strong supplementary communication tool for health care workers when discussing effects and risks of highly toxic substance consumption.
Funder
Fonds de lutte contre certaines formes de criminalité
Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health,Public Health, Environmental and Occupational Health,Medicine (miscellaneous)
Reference10 articles.
1. The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Drug consumption rooms: an overview of provision and evidence (Perspectives on drugs). https://www.emcdda.europa.eu/system/files/media/publications/documents/2734/POD_Drug%20consumption%20rooms.pdf. 2018. Accessed 24 Apr 2023.
2. Milloy MJ, Wood E. Emerging role of supervised injecting facilities in human immunodeficiency virus prevention. Addiction. 2009;104:620–1.
3. Stoltz JA, Wood E, Small W, Li K, Tyndall M, Montaner J, Kerr T. Changes in injecting practices associated with the use of a medically supervised safer injection facility. J Public Health. 2007;29:35–9. https://doi.org/10.1093/pubmed/fdl090.
4. Marshall BD, Milloy MJ, Wood E, Montaner JS, Kerr T. Reduction in overdose mortality after the opening of North America’s first medically supervised safer injecting facility: a retrospective population-based study. Lancet. 2011;377:1429–37. https://doi.org/10.1016/S0140-6736(10)62353-7.
5. Berndt N, Seixas R, Origer A. 2021 L,Etat du phénomène des drogues et des toxicomanies au Grand-Duché de Luxembourg/The state of the drugs problem in the Grand-Duchy of Luxembourg. https://sante.public.lu/fr/publications/e/etat-phenomene-drogues-rapport-relis-2021.html (2022). Accessed 24 Apr 2023.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献